Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131590) titled 'Efficacy and safety of Pola-R-miniCHP regimen in the first-line treatmen... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131594) titled 'Features of Retinal and Choroidal Circulation in Patients with Fabry Dis... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131602) titled 'Construction and Clinical Validation of a Visual-Text Multimodal Large M... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131606) titled 'Effects of the Kang's Diet on Metabolic Indicators and Cognitive Functio... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131613) titled 'Effect of Preoperative Intranasal Dexmedetomidine on Pre-induction Anxie... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131617) titled 'An observational study on the impact of immune checkpoint inhibitors com... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131620) titled 'Evaluate the efficacy and safety of Lactobacillus jensenii in the manage... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131566) titled 'Randomized Clinical Trial Design of Hydrocortisone in the Treatment of N... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131569) titled 'Prospective, Randomized, Controlled Phase II Clinical Study of Nano-Crys... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131567) titled 'Cetuximab combined with bevacizumab for adjuvant treatment after radical... Read More